UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	October 18, 2022 4:30 P.M.

Form:	S-3
CIK: 0001788028 Company Name: Jasper Therapeutics, Inc. File Number: 333-267777